Effect of amlodipine compared to atenolol on small arteries of previously untreated essential hypertensive patients

American Journal of Hypertension

Volumn 15, Issue 2 I, 2002, Pages 105-110

  Schiffrin, Ernesto L ^a   Pu, Qian ^a   Park, Jeong Bae ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Antihypertensive therapy; Blood pressure; Calcium channel blocker; Endothelium; Hypertrophy; Remodeling; blocker

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT;

ACETYLCHOLINE RELEASE; ADULT; AGED; ANTIHYPERTENSIVE ACTIVITY; ARTERY DIAMETER; ARTERY ENDOTHELIUM; ARTICLE; BLOOD PRESSURE REGULATION; BODY MASS; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENDOTHELIUM CELL; ESSENTIAL HYPERTENSION; FEMALE; HEART HYPERTROPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESISTANCE BLOOD VESSEL; VASCULAR ENDOTHELIUM; VASCULAR RESISTANCE;

ACETYLCHOLINE; ADRENERGIC BETA-ANTAGONISTS; ADULT; AMLODIPINE; ANTIHYPERTENSIVE AGENTS; ARTERIES; ATENOLOL; BUTTOCKS; CALCIUM CHANNEL BLOCKERS; DOUBLE-BLIND METHOD; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; REFERENCE VALUES; VASCULAR RESISTANCE; VASODILATION; VASODILATOR AGENTS;

EID: 0036175218     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-7061(01)02290-7     Document Type: Article

References (27)

1. Effects of a β-blocker or a converting enzyme inhibitor on small arteries in essential hypertension
2. Progressive improvement in the structure of resistance arteries of hypertensive patients after 2 years of treatment with an angiotensin I-converting enzyme inhibitor: Comparison with effects of a beta-blocker
3. Effect of antihypertensive treatment on small arteries of patients with previously untreated essential hypertension
4. Comparison of effects of angiotensin I-converting enzyme inhibition and β-blockade for 2 years on function of small arteries from hypertensive patients
5. Effects of long-term antihypertensive treatment with lisinopril on resistance arteries in hypertensive patients with left ventricular hypertrophy
6. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan
7. Blockade of angiotensin II type 1 receptors: Effect on carotid and radial artery structure and function in hypertensive humans
8. Structure and function of resistance arteries of hypertensive patients treated with a β-blocker or a calcium channel antagonist
9. Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findings
10. Angiotensin II induces hypertrophy, not hyperplasia, of cultured rat aortic smooth muscle cells
11. p38 MAP kinase regulates vascular smooth muscle cell collagen synthesis by angiotensin II in SHR but not in WKY
12. Involvement of PYK2 in angiotensin II signaling of vascular smooth muscle cells
13. Acute and chronic effects of drugs with different actions on adrenergic receptors: A comparison between alpha blockers and different types of beta blockers with and without vasodilating effect
14. G-nitro-L-arginine methyl ester treatment does not prevent flow-induced remodeling in mesenteric feed arteries and arcading arterioles
15. The relation between peripheral vascular structure, left ventricular hypertrophy, and ambulatory blood pressure in essential hypertension
16. Correlation of endothelial function in large and small arteries in human essential hypertension
17. Close relation of endothelial function in the human coronary and peripheral circulations
18. Preserved endothelium-dependent vasodilation in patients with essential hypertension
19. Abnormal endothelium dependent vascular relaxation in patients with essential hypertension
20. Indirect evidence for release of endothelium-derived relaxing factor in the human forearm circulation in vivo: Blunted response in essential hypertension
21. Small artery remodeling is the most prevalent (earliest?) manifestation of target organ damage in hypertension
22. In vitro responses of human peripheral small arteries in hypercholesterolemia and effects of therapy
23. Effect of calcium channel blockade or angiotensin converting enzyme inhibition on structure of coronary, renal and other small arteries in SHR
24. Dose-dependent effects of perindopril on blood pressure and small-artery structure
25. Effect of AT1 angiotensin receptor blockade on structure and function of small arteries in SHR
26. Comparison of effects of the angiotensin converting enzyme inhibitor enalapril and the calcium channel antagonist amlodipine on small artery structure and composition, and on endothelial dysfunction in SHR
27. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction